Joao Jose San Martin Neto - 11 Feb 2022 Form 4 Insider Report for AVIENT CORP (AVNT)

Role
SVP & CHRO
Signature
/s/ Lisa K. Kunkle, Power of Attorney For: Joao Jose San Martin Neto
Issuer symbol
AVNT
Transactions as of
11 Feb 2022
Net transactions value
-$132,653
Form type
4
Filing time
15 Feb 2022, 15:57:37 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNT Common Stock Options Exercise +5,100 +65% 12,927 11 Feb 2022 Direct F1, F2
transaction AVNT Common Stock Tax liability $132,653 -2,520 -19% $52.64 10,407 11 Feb 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVNT Restricted Stock Units Options Exercise -5,100 -100% 0 11 Feb 2022 Common Stock 5,100 Direct F1
transaction AVNT Restricted Stock Units Award $0 +3,850 $0.000000 3,850 14 Feb 2022 Common Stock 3,850 Direct F1
transaction AVNT Stock Appreciation Rights Award $0 +13,450 $0.000000 13,450 14 Feb 2022 Common Stock 13,450 $52.64 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Avient common stock.
F2 Includes dividend equivalents earned with respect to the vested restricted stock units.
F3 Represents shares of Avient common stock that were withheld solely to satisfy the tax withholding obligation applicable to the vesting of restricted stock units on February 11, 2022.
F4 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $52.64 per share and no more than one-third of the grant can vest per year during the first three years.